1. G. Premetis and N.E. Labrou (2020). Cloning and characterization of novel enzybiotics from Acinetobacter baumannii bacteriophages as potential antibacterials in the postantibiotic era. Biocatalysis Open Day 2020, EFB Biocatalysis Division, 26th November.

​

2. G.E. Premetis and N.E. Labrou (2021). Developing ways to fight bacterial pathogens: novel enzybiotics for Acinetobacter baumannii. LS2 - Life Sciences Switzerland, Annual Meeting 2021: Mechanisms in Health, disease and ageing, 17-19 February 2021.

​

3. Varotsou and N.E. Labrou (2021).  Cloning and characterization of a new endolysin from P. acnes bacteriophage as a potential enzybiotic candidate. The 10th Annual Conference Of  The International Chemical Biology Society, 'Looking towards the next decade of chemical biology' November 11th – 13th, 2021.

​

4. G.E. Premetis, A. Stathi, A.C. Papageorgiou and N.E. Labrou. Engineering and structural studies of a novel endolysin from A. baumannii phage. 5th International Caparica Conference in Antibiotic Resistance 2022, Portugal.

​

5. C. Varotsou and N.E. Labrou (2022).  Cloning and characterization of a new endolysin from P. acnes bacteriophage as a potential enzybiotic candidate and its engineering to artilysin. 6th Applied Synthetic Biology in Europe, European Federation of Biotechnology, Edinburgh, United Kingdom, 2-4 November 2022.

​

6. Panagiota Pantiora, Nikolaos Georgakis, Nikolaos E. Labrou (2023). New Ways To Fight Bacterial Pathogens: Metagenomics Analysis For The Discovery Of a Thermostable Endolysin With High Bactericidal Activity. 6th World Congress on Targeting Phage Therapy 2023, June 1-2, 2023 – Paris, France.